Vext Science Inc (VV5) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Vext Science Inc (VV5) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.26 Million ≈ $1.47 Million USD) by net assets (€68.41 Million ≈ $79.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Vext Science Inc balance sheet independence to measure how much of total assets are equity-financed.
Vext Science Inc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Vext Science Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check VV5 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Vext Science Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vext Science Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Banimmo SA
BR:BANI
|
-0.184x |
|
B.M.P. PHARMA TRAD (BMP.SG)
STU:BMP
|
N/A |
|
Qleanair Holding AB
ST:QAIR
|
0.114x |
|
NuriFlex Co.Ltd
KQ:040160
|
-0.001x |
|
Valartis Group AG
SW:VLRT
|
-0.010x |
|
Iljin Display
KO:020760
|
-0.010x |
|
KMH Hitech Co. Ltd
KQ:052900
|
0.058x |
|
Pardus Girisim Sermayesi Yatirim Ortakligi A.S.
IS:PRDGS
|
0.024x |
Annual Cash Flow Conversion Efficiency for Vext Science Inc (2017–2024)
The table below shows the annual cash flow conversion efficiency of Vext Science Inc from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Vext Science Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €75.74 Million ≈ $88.54 Million |
€3.29 Million ≈ $3.84 Million |
0.043x | -6.79% |
| 2023-12-31 | €94.98 Million ≈ $111.04 Million |
€4.42 Million ≈ $5.17 Million |
0.047x | -43.43% |
| 2022-12-31 | €71.92 Million ≈ $84.08 Million |
€5.92 Million ≈ $6.92 Million |
0.082x | -58.13% |
| 2021-12-31 | €59.39 Million ≈ $69.44 Million |
€11.68 Million ≈ $13.66 Million |
0.197x | +130.49% |
| 2020-12-31 | €36.31 Million ≈ $42.45 Million |
€3.10 Million ≈ $3.62 Million |
0.085x | +656.98% |
| 2019-12-31 | €25.67 Million ≈ $30.01 Million |
€-393.31K ≈ $-459.82K |
-0.015x | -110.81% |
| 2018-12-31 | €17.00 Million ≈ $19.88 Million |
€2.41 Million ≈ $2.82 Million |
0.142x | -33.46% |
| 2017-12-31 | €8.77 Million ≈ $10.26 Million |
€1.87 Million ≈ $2.19 Million |
0.213x | -- |
About Vext Science Inc
Vext Science, Inc., through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. The company al… Read more